After decades of viewing daily low-dose aspirin as the standard recommendation for preventing cardiovascular disease, it seems the time for change has come. There has been ongoing discussion and study about the value of aspirin for over 30 years in both the treatment and prevention of heart and vascular diseases. For years, doctors prescribed aspirin for … Continue reading Why a healthy lifestyle (not a daily aspirin) is key to preventing heart disease
You’ve probably heard the recommendation: If you’ve already had a heart attack, take a low-dose aspirin daily. But is that enough? Beyond its pain-relieving effects, aspirin blocks an enzyme pathway that helps platelets in the blood stick together. This lowers the risk that blood clots will form, which can lead to heart attack. But it … Continue reading How a simple test can help tailor aspirin doses for heart disease
For many people with heart disease, a daily dose of aspirin helps prevent heart attacks and stroke. But some people need more protection than others. Tailoring the dosage and medication mix for each person has always been a challenge — until we started testing their urine. What we found gave us hope, and it centered … Continue reading Is your daily aspirin protecting your heart? A urine test could tell
New recommendations suggest that an aspirin a day could prevent cardiovascular disease and cancer, according to the U.S. Preventative Services Task Force (USPSTF), an independent advisory panel composed of medical experts. The USPSTF recommends that patients take daily low-dose aspirin if they are between 50–69 years old, have an increased risk of cardiovascular disease, and … Continue reading Could an aspirin a day keep cancer (and heart disease) away?
All too often, we hear or read in the media that eating a certain food, taking a supplement, or changing a behavior will stave off cancer or heart disease, or it will help us lose weight. But it is important that we not take scientific publications for more than they claim to be. In the August edition … Continue reading Don’t Take Recent Prostate Cancer Study At Face Value